This page was created by volunteers like you!
Help us make it even better. To learn more about contributing to MEpedia, click here.
Join the movement
Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
Congratulations!
MEpedia has got over 30 million views as of August 2022!

Tramadol

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Tramadol is a generic pain reliever drug used in the United States. The US brand names are: ConZip, FusePaq Synapryn, rybix ODT, Ryzolt, Ultram and Ultram ER. Unlike traditional opioids, tramadol exerts its effects through a combination of serotonergic and opioid mechanisms, and is thought to be less habit-forming. At high doses it also has noradrenergic effects. Sleep disturbances are commonly reported if taken too close to bedtime, and with the extended-release versions.

It is used for moderate to moderately severe pain, and pain after surgery. The extended release or long acting form is used on chronic pain.[1]

A three-year study showed a correlation between tramadol consumption and seizure occurrence.[2]

Notable studies[edit | edit source]

"In our study, it was seen that seizures occurred both at therapeutic and supratherapeutic ranges without history of epilepsy."[2]

"Conclusion: In conclusion, the neurotoxicity of tramadol commonly manifests as generalized tonic-clonic seizures, most frequently within 24 hours after tramadol intake, and was more common in subjects concomitantly consuming alcohol, illicit drugs, anti-psychotics, or anti-depressants."[2]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. Tramadol - Mayo Clinic
  2. Jump up to: 2.0 2.1 2.2 2.3 Boostani, Reza; Derakhshan, Siavash (2012). "Tramadol induced seizure: A 3-year study". Caspian Journal of Internal Medicine. 3 (3): 484–487. ISSN 2008-6164. PMC 3755854. PMID 24009919.